1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

23 May 2022
Admin
News Article

Sun Pharma Recalls Over 10,000 Bottles Of Generic Anti-Depression Drug In Us

As Per The Usfda, Sun Pharma Is Recalling The Affected Lot Due To "Presence Of Foreign Substance: Customer Complaint For The Presence Of Dark, Gritty Substance Found Within The Bottle, Which Was Determined To Be Activated Carbon From The Desiccant Canister Inside The Bottle". Drug Major Sun Pharma Is Recalling Around 10,500 Bottles Of A Generic Drug Meant For The Treatment Of Major Depressive Disorders In The Us Market Following A Customer Complaint. According To The Latest Enforcement Report Of The Us Food And Drug Administration (Usfda), The Us Arm Of The Domestic Pharma Major Is Recalling 10,548 Bottles Of Bupropion Hydrochloride Extended-Release Tablets In The American Market. The Drug Is Used To Treat Depression And Prevent Seasonal Affective Disorder (Sad). It Is Also Used To Help People Stop Smoking. As Per The Usfda, The Company Is Recalling The Affected Lot Due To "Presence Of Foreign Substance: Customer Complaint For The Presence Of Dark, Gritty Substance Found Within The Bottle, Which Was Determined To Be Activated Carbon From The Desiccant Canister Inside The Bottle The Drugmaker Is Recalling The Product In 150 And 200 Mg Strengths, It Added. The Company Is Recalling 9,804 Bottles Of 150 Mg Strength And 744 Bottles Of 200 Mg Strength, The Us Health Regulator Stated. The Affected Lot Of The Medication Was Manufactured By The Drug Maker In Its Halol (Gujarat) Based Manufacturing Plant. In The Us, The Medication Was Distributed By New Jersey-Based Sun Pharmaceutical Industries Inc. The Company Initiated The Class Iii Nationwide (Us) Voluntary Recall On April 29 This Year. As Per Usfda, A Class Iii Recall Is Initiated In A "Situation In Which Use Of, Or Exposure To, A Violative Product Is Not Likely To Cause Adverse Health Consequences." Earlier This Month, Sun Pharma Had Said That The Usfda Issued A 'Form 483' With Ten Observations After Inspecting Its Halol Plant In Gujarat. As Per Us Fda, A Form 483 Is Issued To A Firm'S Management At The Conclusion Of An Inspection When The Investigator Has Observed Any Conditions That In Its Judgment May Constitute Violations Of The Food Drug And Cosmetic (Fd&C) Act And Related Acts. The Us Health Regulator Conducted A Good Manufacturing Practices (Gmp) Inspection Of The Halol Facility From April 26 To May 9, The Mumbai-Based Drug Maker Had Said In A Regulatory Filing. The Mumbai-Based Sun Pharmaceutical Industries Is The Fourth Largest Specialty Generic Pharmaceutical Company In The World With Global Revenues Of Over Usd 4.5 Billion. With Over 40 Manufacturing Facilities, It Sells Medicines In Over 100 Countries Across The Globe

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!